Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Gene expression profiling in malignant lymphomas.

Henrickson SE, Hartmann EM, Ott G, Rosenwald A.

Adv Exp Med Biol. 2007;593:134-46. Review.

PMID:
17265723
2.

Lymphomas: its gene expression profiling.

Tiwari M.

J Cancer Res Ther. 2011 Oct-Dec;7(4):393-8. doi: 10.4103/0973-1482.91998. Review.

3.

Clinical translation of gene expression profiling in lymphomas and leukemias.

Rosenwald A, Staudt LM.

Semin Oncol. 2002 Jun;29(3):258-63. Review.

PMID:
12063678
4.

Diagnostic and prognostic significance of gene expression profiling in lymphomas.

Leich E, Hartmann EM, Burek C, Ott G, Rosenwald A.

APMIS. 2007 Oct;115(10):1135-46. Review.

PMID:
18042147
5.

Towards molecular diagnosis and targeted therapy of lymphoid malignancies.

Wiestner A, Staudt LM.

Semin Hematol. 2003 Oct;40(4):296-307. Review.

PMID:
14582080
6.

DNA microarrays in lymphoid malignancies.

Rosenwald A.

Oncology (Williston Park). 2003 Dec;17(12):1743-8; discussion 1750, 1755, 1758-9 passim. Review.

7.
8.

Molecular diagnosis of lymphoid malignancies by gene expression profiling.

Davis RE, Staudt LM.

Curr Opin Hematol. 2002 Jul;9(4):333-8. Review.

PMID:
12042708
9.

Gene expression profiling of lymphoid malignancies.

Staudt LM.

Annu Rev Med. 2002;53:303-18. Review.

PMID:
11818476
10.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
11.

Gene expression analysis in aggressive NHL.

Chan WC, Huang JZ.

Ann Hematol. 2001;80 Suppl 3:B38-41.

PMID:
11757704
12.

Multi-class cancer classification via partial least squares with gene expression profiles.

Nguyen DV, Rocke DM.

Bioinformatics. 2002 Sep;18(9):1216-26.

PMID:
12217913
13.

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.

Green MR, Jardine P, Wood P, Wellwood J, Lea RA, Marlton P, Griffiths LR.

BMC Cancer. 2010 May 12;10:195. doi: 10.1186/1471-2407-10-195.

14.

[DNA-chips in the diagnosis of hematological malignancies].

Feuring-Buske M, Hartmann EM, Ott G, Reuter H, Buske C, Rosenwald A.

Internist (Berl). 2006 Jan;47(1):39-46. Review. German.

PMID:
16247632
15.
16.

Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?

Iqbal J, Naushad H, Bi C, Yu J, Bouska A, Rohr J, Chao W, Fu K, Chan WC, Vose JM.

Blood Rev. 2016 Mar;30(2):73-88. doi: 10.1016/j.blre.2015.08.002. Epub 2015 Aug 18. Review.

PMID:
26432520
17.

[Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].

Tagawa H.

Gan To Kagaku Ryoho. 2007 Jul;34(7):975-82. Review. Japanese.

PMID:
17637530
18.

Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma.

Dybkaer K, Iqbal J, Zhou G, Chan WC.

Clin Lymphoma. 2004 Jun;5(1):19-28. Review.

PMID:
15245604
19.

Gene expression profiling in diffuse large B-cell lymphoma.

Morgensztern D, Martin MG, Lossos IS.

Leuk Lymphoma. 2007 Apr;48(4):669-82. Review.

PMID:
17454624
20.

The use of genetic microarray analysis to classify and predict prognosis in haematological malignancies.

Levene AP, Morgan GJ, Davies FE.

Clin Lab Haematol. 2003 Aug;25(4):209-20. Review.

PMID:
12890159

Supplemental Content

Support Center